Generics 143

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Linezolid manufacturers

143 products found

Filters

143 products found

linezolid

Bags for injection/infusion 2 mg/ml - 300 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Distribution only
Comments
Ref: Zyvoxid®
Manufacturer #10720

It is one of the oldest pharmaceutical companies specializing in generic mostly for the hospital segment. The key products offered are life-saving medicines, especially in the CNS and cardiovascular therapeutic group. The company follows and complies with the EU GMP requirements.

Manufacturer usually replies in 4 days

linezolid

Solution for infusion 600 mg/300 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

linezolid

Tablets, film coated 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 3 days

linezolid

Solution for infusion 2 mg/ml - 300 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 7 days

linezolid

Tablets, film coated 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
DCP successful, RMS SE
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

linezolid

Solution for infusion 2mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #16268
It is a private corporation that was established in the early 2000s. They are a multinational healthcare company that focuses on infusion and clinical nutrition medications and solutions. The Company's success is based on ideals of transparency, credibility, and loyalty, which are principles that represent a company's heritage: its reputation.

Manufacturer usually replies in 8 days

linezolid

Solution for infusion 2 mg/ml - 300 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq , United Arab Emirates
Available for
Licensing with supply
Manufacturer #9267

A highly trusted and reliable name for WHO-approved pharmaceutical products that deals in exports as well. With modern facilities and excellent product conditions, they are known to provide superlative services aimed at keeping the community disease-free and healthy at the same time.

Manufacturer usually replies in 8 days

linezolid

Solution for infusion 2 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Croatia
Manufacturer #12799
It is a generic pharmaceutical producer and sales organization based in Western Europe that was created in the 1990s. The company's broad portfolio includes high-quality complex dosage forms, such as liquid, injectable, dry powder, and lyophilisate items, and it specializes in supplying hospitals and pharmacies with selected products. It continues to grow steadily, and its focus on high-quality items, excellent service, and the development of strong relationships remains strong, attesting to the company's reputation.

Manufacturer usually replies in 5 days

linezolid

Tablets, film coated 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Chile , Turkey , Vietnam , Panama
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

linezolid

Tablets 600mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 4 days

linezolid

Oral suspension 100mg/5ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 4 days

linezolid

Solution for injection 600mg/300ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 4 days

linezolid

Tablets 600mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Germany , Slovakia , Czech Republic , Poland , Romania , Netherlands
Manufacturer #6978

Manufacturer usually replies in 3 days

linezolid

Tablets 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077

Manufacturer usually replies in nan days

linezolid

Tablets, film coated 600 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #3044

Manufacturer usually replies in nan days

linezolid

Tablets, film coated 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18268

Manufacturer usually replies in 4 days

linezolid

Tablets, film coated 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
Manufacturer #22627

Manufacturer usually replies in 4 days

linezolid

Tablets 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

linezolid

Solution for infusion 2 mg/ml - 300 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Unavailable markets
Vietnam
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

linezolid

Tablets, film coated 600 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO, EU GMP
Manufacturer #21022

Manufacturer usually replies in 8 days

Want to view all 143 products? Create your free account today!

Linezolid

Linezolid is an antibiotic primarily used for treating infections resulting due to gram-positive bacteria resistant to other antibiotics. It is quite effective against most of the gram-positive bacteria that result in a disease such as Staphylococcus aureus. It is beneficial for treating infections of pneumonia and skin. However, it can also be used for treating other infections including drug-resistant tuberculosis. It is taken either by mouth or given by injection into a vein. Linezolid is quite safe when given for a short duration. It can be given to people of all ages including those with poor kidney function and liver disease. The common side effects noted are nausea, rash, diarrhea, and headache.
Linezolid works by suppressing bacterial protein production as a protein synthesis inhibitor. This either results in the death of the bacteria or inhibits the growth entirely. Although most of the antibiotics work this way, the exact mechanism of this drug is unique. It cuts down protein production entirely. This drug belongs to the oxazolidinone class of medications. Linezolid was approved for medical use in 2000. The wholesale cost of this drug in the developing world is around £2.31 per day. However, the wholesale cost elsewhere is around £11. It is a much cost-effective option in comparison to vancomycin.

Medical uses of Linezolid

The main use of this drug is in the treatment of severe infections resulting due to gram-positive bacteria that have developed resistance against other antibiotics. It cannot be used against bacteria that are sensitive to drugs having a narrow spectrum of activity such as cephalosporins and penicillins. This drug is called a reserve antibiotic as it can remain effective if it is used sparingly. It should be used as the last drug of resort against intractable infections. The manufacturers in the UK mention cSSSIs and pneumonia as the only indications during product labeling. The best thing about this drug is that it is safe and effective for use in newborns and children.

Synthesis of Linezolid

Linezolid manufacturers derive this drug from a synthetic process. It is not available in nature. Many approaches have been studied for the synthesis of this drug. The original method is lengthy and requires the use of expensive chemicals despite the good yield. The high cost of this drug is because of the expensive procedure involved in its synthesis. A cost-effective and concise mechanism was developed in 1998 by Upjohn. Later, an Indian pharmaceutical company called Dr. Reddy’s developed an atom-economical method in 1999.

History of Linezolid

The oxazolidinones have been known since the 1950s. Researchers discovered their antimicrobial properties in the 1970s. A series of derivatives of this chemical was patented by DuPont in 1978. The scientists at DuPont gave a detailed description of a new class of antibiotics called oxazolidinones. Several research programs were carried out by other laboratories in the 1990s. Linezolid was quite an expensive drug in 2009. A treatment course cost £1590 alone. This is not inclusive of hospital stay charges. The price decreased drastically when the medication became generic.

Find reliable Linezolid manufacturers and Linezolid suppliers

Distributors who are keen on monetizing the potential of this drug can connect with reliable Linezolid suppliers on the Pipelinepharma platform. It is a trusted platform and enlists manufacturers only after verifying the quality of their offerings. The distributors can shortlist manufacturers using advanced search filters. It is quite easy to find partners in the global pharma industry if you rely on a platform such as Pipelinepharma.